Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous MSCs in Chronic Spinal Cord Injury
NCT02574585Phase 2Unknown
- Sponsor
- Hospital São Rafael
- Start
- Dec 2019
- Primary completion
- Dec 2021
- Modality
- Stem Cell Therapies
01
Overview
A Phase 2 trial of autologous bone marrow derived mesenchymal stromal cells in spinal cord injury (SCI), sponsored by Hospital São Rafael. Status: unknown.
02
Drugs
autologous bone marrow derived mesenchymal stromal cells
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT02574585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02574585.